By
Jennifer Furin,
Gunta Dravniece
Published: Oct. 27, 2015, 11:23 p.m.·
Tags:
Drug-resistant TB
In the “Implementation Innovations” webinar series from USAID and SIAPS, Dr. Jennifer Furin and Dr. Gunta Dravniece presented on October 13, 2015 about new TB drug delamanid. This webinar provided up-to-date information on the use of delamanid for treatment of patients under program conditions. This webinar may be of special interest to consultants, program managers, and clinicians working in the field of drug-resistant TB.
Read More →